Cardiac CT's Role in Asymptomatic Patients With Diabetes and Metabolic Syndrome (CTRAD)
Role of Cardiac CT in Risk Factor Control in Asymptomatic Patients With Diabetes
Sponsor: University of California, Irvine
This NA trial investigates Diabetes and Metabolic Syndrome and is currently completed. University of California, Irvine leads this study, which shows 8 recorded versions since 2008 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Sep 2021 — Dec 2022 [monthly]
Completed NA
▶ Show 3 earlier versions
-
Jan 2021 — Sep 2021 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Jul 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of California, Irvine
For direct contact, visit the study record on ClinicalTrials.gov .